Pharmascience Canada is proud to launch pms-CINACALCET, a generic medicine with multiple indications!

Pharmascience Canada is proud to launch pms-CINACALCET tablets in 30 mg, 60 mg, and 90 mg.

These tablets are bioequivalent to the brand name Sensipar® (Cinacalcet) of Amgen Inc, and are indicated for:

  • The treatment of secondary hyperparathyroidism (HPT) in patients with Chronic Kidney Disease (CKD) receiving dialysis;
  • The control of parathyroid hormone levels, calcium and phosphorous levels, and the serum calcium-phosphorous product (Ca x P), in patients with CKD receiving dialysis;
  • The reduction of hypercalcemia in patients with parathyroid carcinoma;
  • The reduction of clinically significant hypercalcemia, as defined by relevant treatment guidelines, in patients with primary HPT for whom parathyroidectomy is not clinically appropriate or is contraindicated.

 

ABOUT PHARMASCIENCE INC.

Founded in 1983, Pharmascience Inc. is the largest pharmaceutical employer in Quebec with 1,500 employees proudly headquartered in Montreal. Pharmascience Inc. is a full-service privately owned pharmaceutical company with strong roots in Canada and a growing global reach with product distribution in over 50 countries. Ranked 47th among Canada’s top 100 Research & Development (R&D) investors in 2020, with 40-50 million dollars invested each year, Pharmascience Inc. is among the largest drug manufacturers in Canada.

Pharmascience Inc. has strong values based on the importance of investing in its employees and young people. Through various programs and initiatives, the company ensures it supports their personal development and life. In 2022, Pharmascience Inc. has proudly been recognized for its investments by being selected as one of Canada’s Top Employers for Young People and named as one of Montreal’s best employers, as part of the Canada’s Top 100 Employers project. Pharmascience is now certified as a Great Place to Work.

For product information, please contact Pharmascience’s Medical Information Department at 1-888-550-6060.

SENSIPAR® is a registered trademark of Amgen Inc.

Published in

Product Launches